AUTOLOGOUS BONE MARROW TRANSPLANTATIONI I. Clinicai primary application
Huang Shengli, et al. (Department of Oncology, Affiliated Hospital of Bengbu Medical College, Anhui)
Autologous bone marrow transplantation ( ABMT ) was undertaker, in 7 cases of brain tumor, 48 hours after intensive chemotherapy ( CCNU 260-390mg/m2 ). The average count of returned nuclear cells was 2.54 × 10~8/kg. The reponse rate was 55% ( 4/7 ) . ABMT could accelerate the hemaatopoietic restoration and reduce or alleviate the late bone marrow suppression caused by CCNU. This primary experience will provide us with a belter prospect for other kinds of malignancy in our clinical practice of the intensive chemotherapy.